Author

Nithya Prasannan

Observed names: N. Prasannan, Prasannan, N

Institutions: National Health Service, University College London Hospitals NHS Foundation Trust, University College London

Observed institutions: National Health Service, University College Hospital, University College London Hospitals NHS Foundation Trust, Royal Free London NHS Foundation Trust, Queen's Hospital, University College London

ORCID: 0009-0007-6177-7162

Observed ORCID: 0009-0007-6177-7162

OpenAlex ID: A5000336689

Impaired exercise capacity in post–COVID-19 syndrome: the role of VWF-ADAMTS13 axis

2022 · Nithya Prasannan, Melissa Heightman, et al. · Blood Advances · 68

PDF

The use of obinutuzumab and ofatumumab in the treatment of immune thrombotic thrombocytopenic purpura

2022 · Andrew J. Doyle, Matthew J. Stubbs, et al. · British Journal of Haematology · 35

Delayed normalisation of ADAMTS13 activity in acute Thrombotic Thrombocytopenic Purpura in the caplacizumab era

2023 · Nithya Prasannan, Mari Thomas, et al. · Blood · 31

PDF

Peak ADAMTS13 activity to assess ADAMTS13 conformation and risk of relapse in immune-mediated thrombotic thrombocytopenic purpura

2024 · Nithya Prasannan, Bertina Dragunaite, et al. · Blood · 18

Novel antiplatelet strategies targeting VWF and GPIb

2020 · Nithya Prasannan, Marie Scully · Platelets · 16

A HaemSTAR-led, UK-wide ‘flash-mob’ audit of intravenous immunoglobulin use in immune thrombocytopenia

2019 · Phillip Nicolson, Rita Perry, et al. · Clinical Medicine · 3

Familial hypercholesterolaemia: identification and management. Evidence reviews for case-finding, diagnosis and statin monotherapy

2017 · Pilling, S, Gray, J, et al. · St George's Online Research Archive (St George's University of London) · 3

PDF

Coagulation in Kidney Disease

2022 · Nithya Prasannan, Suzanne H. Forbes, et al. · Springer eBooks · 2

A HaemSTAR-led, UK-wide 'flash-mob’ audit of intravenous immunoglobulin use in immune thrombocytopenia

2019 · Phillip Nicolson, Rita Perry, et al. · Clinical Medicine · 1

PDF

OC 67.3 Anti-ADAMTS13 IgG antibody boosting associated with delayed ADAMTS13 normalisation in a subgroup of caplacizumab/PEX treated patients

2026 · Nithya Prasannan, Arshia Latif, et al. · Research and Practice in Thrombosis and Haemostasis

PB3589 Development of an Automated Machine Learning Approach to aid Thrombotic Thrombocytopenic Purpura (TTP) Diagnosis

2026 · John-Paul Westwood, Holger Kunz, et al. · Research and Practice in Thrombosis and Haemostasis

Recurrent thrombocytopenia in immune thrombotic thrombocytopenic purpura during the caplacizumab era

2026 · M. Subhan, C. Cox, et al. · British Journal of Haematology

PDF

Delayed ADAMTS13 normalization in caplacizumab/PEX–treated patients associated with anti-ADAMTS13 IgG antibody boosting

2026 · Nithya Prasannan, Arshia Latif, et al. · Blood Advances

Extended duration anticoagulation in cancer associated thrombosis

2025 · Olabisi Ogunbiyi, Anuradha Bhide, et al. · Blood

PDF

Comparing the Impact of Rituximab Dosing on Longitudinal ADAMTS13 Parameters in TTP

2023 · Maryam Subhan, Nithya Prasannan, et al. · Blood

PDF

P1598: Utility of ‘open/closed’ Adamts13 in Monitoring Immune Ttp

2023 · Nithya Prasannan, Bertina Dragunaite, et al. · HemaSphere

Long Covid: Evidence of Persistent Abnormalities in Thrombotic Markers and Correlation with Functional Impairment

2022 · E. Brennan, N. Prasannan, et al.

Works count: 17

Citation count: 177

H-index: 5

I10-index: 5